HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Denham, J. Search for Related Content PubMed PubMed Citation Articles by Denham, J.

The Use of Prochlorperazine (Stemetil) in Chronic Psychotic Disorders

Whitchurch Hospital, Cardiff

ABSTRACT

The effect of prochlorperazine on psychiatric patients has been investigated and found to be of value in the treatment of severely disturbed schizophrenics. It was found to be of little use in other psychiatric conditions.

The main side-effect was a type of Parkinsonism which provoked alarm in the patient and those around him. This disappeared on withdrawal of the drug or when promethazine was administered concurrently.

Prochlorperazine in doses effective for psychiatric conditions should be employed mainly in mental hospitals.

(Prochlorperazine, under the trade mark of "Stemetil", was provided by May & Baker, Dagenham.)